Class 2 MHRA medicines recall – Abstral 200microgram sublingual tablets (Kyowa Kirin)

Drug alert number: EL (20)A/34

Date issued: 29 July 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Abstral 200microgram sublingual tablets PL 16508/0031

Kyowa Kirin Limited is recalling the above batch as a precautionary measure, due to the reports of double tablets in a single blister pocket. This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.

Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further information

Full drug alert can be viewed here.

For Stock control enquiries please contact: Stuart Hay, Commercial Director

• Telephone: +44 (0) 1896 664045
• Mobile: +44 (0) 7968 983286
• E-mail: Stuart.Hay@kyowakirin.com

For Medical information enquiries please contact:

• Medical Information Direct Line: + 44 (0)1896 664 000
• E-mail: medinfo@kyowakirin.com

For Quality information please contact: Martin Smith (Responsible Person)

• Telephone: +44 7904671807
• E-mail: Martin.Smith@kyowakirin.com